venBio Global Strategic Fund II L.P., 10% Owner at Akero Therapeutics, Inc. (AKRO), sold 31,354 shares at $19.86 ($623K) on 2020-01-08, disclosed to the SEC on 2020-01-10.
Open-market sale of $623k AKRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.86 | 15,677 | $311K | 50.0% |
| 2 | $19.86 | 15,677 | $311K | 50.0% |
| Total | $19.86 avg | 31,354 | $623K | 100% |
| Filing → |
| CMPI | SELL | 2022-04-29 | $3.2M | — | Filing → |
| IMPL | BUY | 2021-04-29 | $6.8M | — | Filing → |
| AKRO | SELL | 2020-07-06 | $8.0M | — | Filing → |